跳至主要内容
临床试验/NCT06546865
NCT06546865招募中不适用

Slim Sheath 22F Holmium Laser Enucleation of the Prostate (HoLEP) Technique vs 26 F Sheath HoLEP for Treatment of Benign Prostatic Hyperplasia (BPH): A Randomized Prospective Comparative Study

Thunder Bay Regional Health Research Institute2 个研究点 分布在 1 个国家目标入组 142 人开始时间: 2024年4月16日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
142
试验地点
2
主要终点
Comparison of Operating Time

研究概览

简要总结

Holmium laser enucleation of the prostate (HoLEP) is routinely performed with 24F, 26F, and 28F laser scopes. Proponents of larger caliber scopes suggest that the larger scope size allows for improved visualization, hemostasis, and operative efficiencies. Proponents of a smaller scope diameter suggest that by eliminating the need for pre-HoLEP urethral dilation to accommodate a larger scope. It has also been proposed that a smaller caliber scope is less traumatic to the urethra resulting in lower rates of bladder neck contracture and urethral stricture disease. Currently, to our knowledge, there are no level one evaluation examining scope size 22F versus 26F sheath in laser enucleation outcomes. The aim of our study is to determine if a smaller diameter scope is associated with improved laser enucleation time, post-operative recovery, rates of same-day discharge, or increasing intra-operative or postoperative complication rates

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Males over 50 years of age at the time of enrollment
  • Referred to urology for refractory LUTS secondary to BPH
  • Failed medical (non-surgical) treatment
  • Prostate size on preoperative TRUS of > 80 ml
  • IPSS >15, QOL score ≥3 and Qmax <15 ml/sec
  • Written informed consent to participate in the study
  • Ability to comply with the requirements of the study procedures

排除标准

  • Previous surgical treatment for BPH
  • History of prostate cancer
  • Prostate size < 80 mL
  • History of urethral stenosis or its management
  • Known or suspected neurogenic bladder
  • Participants with active urinary tract infection until appropriately treated
  • Participants with preexisting conditions, which, in the opinion of the investigator, interfere with the conduct of the study

结局指标

主要结局

Comparison of Operating Time

时间窗: Intra-op

Operating time as measured during the procedure measured in minutes.

次要结局

  • Quality of Life (QOL) as scored on the International Prostate Symptom Score (IPSS)(One year post-procedure)
  • Length of Hospital Stay(Within 6 hours of procedure completion)
  • Time to Catheter Removal(Within 6 hours of procedure completion)
  • Continence status(One year post-procedure)
  • International Prostate Symptom Score(One year post-procedure)
  • Rate of Complications(One year post-procedure)
  • Peak flow rate(One year post-procedure)
  • Post-void residual(One year post-procedure)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验